» Articles » PMID: 32138326

Tuberous Sclerosis Complex Axis Controls Renal Extracellular Vesicle Production and Protein Content

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Mar 7
PMID 32138326
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The tuberous sclerosis complex (Tsc) proteins regulate the conserved mTORC1 growth regulation pathway. We identified that loss of the gene in mouse inner medullary collecting duct (mIMCD) cells induced a greater than two-fold increase in extracellular vesicle (EV) production compared to the same cells having an intact axis. We optimized EV isolation using a well-established size exclusion chromatography method to produce high purity EVs. Electron microscopy confirmed the purity and spherical shape of EVs. Both tunable resistive pulse sensing (TRPS) and dynamic light scattering (DLS) demonstrated that the isolated EVs possessed a heterogenous size distribution. Approximately 90% of the EVs were in the 100-250 nm size range, while approximately 10% had a size greater than 250 nm. Western blot analysis using proteins isolated from the EVs revealed the cellular proteins Alix and TSG101, the transmembrane proteins CD63, CD81, and CD9, and the primary cilia Hedgehog signaling-related protein Arl13b. Proteomic analysis of EVs identified a significant difference between the -intact and -deleted cell that correlated well with the increased production. The EVs may be involved in tissue homeostasis and cause disease by overproduction and altered protein content. The EVs released by renal cyst epithelia in TSC complex may serve as a tool to discover the mechanism of TSC cystogenesis and in developing potential therapeutic strategies.

Citing Articles

Tuberous Sclerosis Complex and the kidneys: what nephrologists need to know.

Monich A, Bissler J, Barreto F J Bras Nefrol. 2024; 46(3):e20240013.

PMID: 38991206 PMC: 11239183. DOI: 10.1590/2175-8239-JBN-2024-0013en.


Physiologically Based Pharmacokinetic Modeling of Extracellular Vesicles.

Kumar P, Mehta D, Bissler J Biology (Basel). 2023; 12(9).

PMID: 37759578 PMC: 10525702. DOI: 10.3390/biology12091178.


Tuberous Sclerosis Complex cell-derived EVs have an altered protein cargo capable of regulating their microenvironment and have potential as disease biomarkers.

Bhaoighill M, Falcon-Perez J, Royo F, Tee A, Webber J, Dunlop E J Extracell Vesicles. 2023; 12(6):e12336.

PMID: 37337371 PMC: 10279809. DOI: 10.1002/jev2.12336.


Arginine depletion attenuates renal cystogenesis in tuberous sclerosis complex model.

Amleh A, Pri Chen H, Watad L, Abramovich I, Agranovich B, Gottlieb E Cell Rep Med. 2023; 4(6):101073.

PMID: 37290438 PMC: 10313931. DOI: 10.1016/j.xcrm.2023.101073.


Specific Features of Focal Cortical Dysplasia in Tuberous Sclerosis Complex.

Bychkova E, Dorofeeva M, Levov A, Kislyakov A, Karandasheva K, Strelnikov V Curr Issues Mol Biol. 2023; 45(5):3977-3996.

PMID: 37232723 PMC: 10217757. DOI: 10.3390/cimb45050254.


References
1.
Patel B, Patel J, Cho J, Manne S, Bonala S, Henske E . Exosomes mediate the acquisition of the disease phenotypes by cells with normal genome in tuberous sclerosis complex. Oncogene. 2015; 35(23):3027-36. DOI: 10.1038/onc.2015.358. View

2.
Tian Y, Gong M, Hu Y, Liu H, Zhang W, Zhang M . Quality and efficiency assessment of six extracellular vesicle isolation methods by nano-flow cytometry. J Extracell Vesicles. 2019; 9(1):1697028. PMC: 6896440. DOI: 10.1080/20013078.2019.1697028. View

3.
Bissler J, Zadjali F, Bridges D, Astrinidis A, Barone S, Yao Y . Tuberous sclerosis complex exhibits a new renal cystogenic mechanism. Physiol Rep. 2019; 7(2):e13983. PMC: 6344348. DOI: 10.14814/phy2.13983. View

4.
Garnier D, Magnus N, Meehan B, Kislinger T, Rak J . Qualitative changes in the proteome of extracellular vesicles accompanying cancer cell transition to mesenchymal state. Exp Cell Res. 2013; 319(17):2747-57. DOI: 10.1016/j.yexcr.2013.08.003. View

5.
Hallal S, Russell B, Wei H, Lee M, Toon C, Sy J . Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance. Proteomics. 2018; 19(1-2):e1800157. DOI: 10.1002/pmic.201800157. View